Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation
about
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma.Minireview: progress and challenges in proteomics data management, sharing, and integrationCombinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas.Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis.Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assaysDexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.Implications of functional proteomics in breast cancer.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Molecular determinants of lung cancer metastasis to the central nervous system.A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection.Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.
P2860
Q28548486-F89ED81D-F402-4B79-A98D-A01D44D61EB7Q28727478-476D2336-4C7B-478E-BCDB-D9C14A64507EQ30277902-DBB03C26-8CB6-45CD-A6C1-455044798C9AQ31138811-B5078372-BFF4-46EE-A611-D5BB6BFAA6ABQ33850616-08E12568-5497-436C-859B-B4CB50DDC989Q34494886-59567031-D1DD-4779-A9CB-B1DBFB0D879AQ35560129-B1C8BD47-4A19-495A-9A7D-797FA7259778Q35631966-5554DF87-DD51-42D7-8DD7-B2792BD57216Q36715955-86CBBB82-1B6E-4C35-8477-BC032B35971AQ37056891-89B109BF-B0BF-4104-91AC-DCEE16DD40DFQ37166443-20FA0565-73FE-4E86-AB9E-BC64713F226CQ37698227-25F8D2F6-AD28-4DDA-ABE6-2D4035B643A5Q38148583-D52CE92D-8692-49CB-8CB7-A05A84E530C8Q38390049-36CCA533-92D5-45E1-BA04-C14222BCDAE9Q38973213-D58FE84C-3A8A-4941-BD1B-DA8E26A9A3D9Q52087016-86ADDDF4-AAF7-4B59-80E0-2A0E377A18CD
P2860
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protein pathway activation map ...... pecific drug target activation
@ast
Protein pathway activation map ...... pecific drug target activation
@en
type
label
Protein pathway activation map ...... pecific drug target activation
@ast
Protein pathway activation map ...... pecific drug target activation
@en
prefLabel
Protein pathway activation map ...... pecific drug target activation
@ast
Protein pathway activation map ...... pecific drug target activation
@en
P2093
P2860
P50
P356
P1476
Protein pathway activation map ...... pecific drug target activation
@en
P2093
Angela Zupa
Emanuel F Petricoin
Giuseppina Improta
Jianghong Deng
Julia D Wulfkuhle
Lance A Liotta
William Broaddus
P2860
P304
P356
10.1021/PR200065T
P577
2011-05-27T00:00:00Z